Thomas Maino
Family Medicine · Summerville, SCNPI 1659323640
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,836 of the $7,387 with a category attached, or 65.5%. 36 manufacturers reported payments, led by Arthrex at 25.8% of the total. Reporting peaked in 2019 at $2,641 and has fallen 94.6% since, to $143 in 2024. Among family medicine clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $28.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Gemini Mountain Medical, LLC$734
- AbbVie$693
- Supernus Pharmaceuticals, Inc.$564
- Lilly USA, LLC$494
- AstraZeneca$428
- plus $3K from 30 others
What the payments were for
- Travel & lodging$6799%
- Food & beverage$4,83665%
- Education$1,87225%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,907 |
| Gemini Mountain Medical, LLC | 3 | $734 |
| AbbVie(2 entities) | 46 | $693 |
| Supernus Pharmaceuticals, Inc. | 18 | $564 |
| Lilly USA, LLC | 26 | $494 |
| AstraZeneca | 17 | $428 |
| GSK | 22 | $379 |
| Novo Nordisk | 20 | $318 |
| Novartis | 15 | $228 |
| Amarin Pharma, Inc. | 10 | $169 |
| Biohaven Pharmaceuticals, Inc. | 9 | $168 |
| Bayer | 6 | $147 |
| Xeris Pharmaceuticals, Inc. | 6 | $129 |
| Pfizer | 8 | $126 |
| Johnson & Johnson | 8 | $108 |
| Amgen | 5 | $103 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $83 |
| Upsher-smith Laboratories LLC | 5 | $79 |
| Boehringer Ingelheim | 5 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Exact Sciences | 3 | $58 |
| Shield Therapeutics Inc | 1 | $54 |
| Eisai Inc. | 3 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Avanir Pharmaceuticals, Inc. | 1 | $27 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Halozyme Inc | 1 | $14 |
| Merck | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
How this compares
$7,387 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $268 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Summerville
- Jennifer StolinSummerville$59K
- Jan BurgerSummerville$16K
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.